Apixaban: an oral direct factor-xa inhibitor

D Jiménez, RD Yusen, E Ramacciotti - Advances in therapy, 2012 - Springer
Apixaban is a highly selective, reversible, direct factor Xa inhibitor that inhibits both free
factor Xa and prothrombinase activity, and clot-bound factor Xa activity. A predictable …
被引用次数：32 相关文章

Apixaban: an oral direct factor-xa inhibitor

D Jiménez, RD Yusen… - Advances in …, 2012 - pubmed.ncbi.nlm.nih.gov
Apixaban is a highly selective, reversible, direct factor Xa inhibitor that inhibits both free
factor Xa and prothrombinase activity, and clot-bound factor Xa activity. A predictable …

Apixaban: An oral direct factor-Xa inhibitor

D Jiménez, RD Yusen, E Ramacciotti - Advances in Therapy, 2012 - profiles.wustl.edu
Apixaban is a highly selective, reversible, direct factor Xa inhibitor that inhibits both free
factor Xa and prothrombinase activity, and clot-bound factor Xa activity. A predictable …

Apixaban: an oral direct factor-xa inhibitor.

D Jiménez, RD Yusen, E Ramacciotti - Advances in Therapy, 2012 - europepmc.org
Apixaban is a highly selective, reversible, direct factor Xa inhibitor that inhibits both free
factor Xa and prothrombinase activity, and clot-bound factor Xa activity. A predictable …

Apixaban: an Oral Direct Factor-Xa Inhibitor

D Jiménez, RD Yusen, E Ramacciotti - Advances in Therapy, 2012 - infona.pl
Apixaban is a highly selective, reversible, direct factor Xa inhibitor that inhibits both free
factor Xa and prothrombinase activity, and clot-bound factor Xa activity. A predictable …

[引用][C] Apixaban: an Oral Direct Factor-Xa Inhibitor

D Jiménez, RD Yusen, E Ramacciotti - Advances in Therapy, 2012 - Springer